Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 57

    1.

    Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study.

    Rutten MJ, Gaarenstroom KN, Van Gorp T, van Meurs HS, Arts HJ, Bossuyt PM, Ter Brugge HG, Hermans RH, Opmeer BC, Pijnenborg JM, Schreuder HW, Schutter EM, Spijkerboer AM, Wensveen CW, Zusterzeel P, Mol BW, Kenter GG, Buist MR.

    BMC Cancer. 2012 Jan 20;12:31. doi: 10.1186/1471-2407-12-31.

    PMID:
    22264278
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer.

    Lenhard M, Tsvilina A, Schumacher L, Kupka M, Ditsch N, Mayr D, Friese K, Jeschke U.

    BMC Cancer. 2012 Jan 3;12:2.

    PMID:
    22214378
    [PubMed - in process]
    Free PMC Article
    3.

    The PACOVAR-trial: a phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer.

    Eichbaum M, Mayer C, Eickhoff R, Bischofs E, Gebauer G, Fehm T, Lenz F, Fricke HC, Solomayer E, Fersis N, Schmidt M, Wallwiener M, Schneeweiss A, Sohn C.

    BMC Cancer. 2011 Oct 20;11:453.

    PMID:
    22014006
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study.

    Gao Y, Liu Z, Chen X, Luo W, Zhang L, Wang J.

    BMC Cancer. 2011 Oct 11;11:439.

    PMID:
    21989202
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation.

    Sernbo S, Gustavsson E, Brennan DJ, Gallagher WM, Rexhepaj E, Rydnert F, Jirström K, Borrebaeck CA, Ek S.

    BMC Cancer. 2011 Sep 24;11:405.

    PMID:
    21943380
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer.

    Xia X, Ma Q, Li X, Ji T, Chen P, Xu H, Li K, Fang Y, Weng D, Weng Y, Liao S, Han Z, Liu R, Zhu T, Wang S, Xu G, Meng L, Zhou J, Ma D.

    BMC Cancer. 2011 Sep 21;11:399.

    PMID:
    21933447
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study.

    Newton MJ, Hayes SC, Janda M, Webb PM, Obermair A, Eakin EG, Wyld D, Gordon LG, Beesley VL.

    BMC Cancer. 2011 Sep 8;11:389.

    PMID:
    21899778
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas.

    Noske A, Schwabe M, Weichert W, Darb-Esfahani S, Buckendahl AC, Sehouli J, Braicu EI, Budczies J, Dietel M, Denkert C.

    BMC Cancer. 2011 Jul 14;11:294.

    PMID:
    21756326
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation.

    Cui J, Miner BM, Eldredge JB, Warrenfeltz SW, Dam P, Xu Y, Puett D.

    BMC Cancer. 2011 Jun 28;11:280.

    PMID:
    21711548
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer.

    Lu R, Sun M, Feng J, Gao X, Guo L.

    BMC Cancer. 2011 Jun 25;11:270.

    PMID:
    21702971
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    Bilateral ovarian teratoma complicated with carcinosarcoma in a 68 year old woman: a case report.

    Shanmughapriya S, SenthilKumar G, Balakrishnan K, Vasanthi N, Vinodhini K, Natarajaseenivasan K.

    BMC Cancer. 2011 Jun 3;11:218. doi: 10.1186/1471-2407-11-218.

    PMID:
    21639901
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients.

    Legge F, Paglia A, D'Asta M, Fuoco G, Scambia G, Ferrandina G.

    BMC Cancer. 2011 May 31;11:214. doi: 10.1186/1471-2407-11-214.

    PMID:
    21627839
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients.

    Lane D, Matte I, Rancourt C, Piché A.

    BMC Cancer. 2011 May 30;11:210.

    PMID:
    21619709
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Analysis of the mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer.

    Davis SJ, Choong DY, Ramakrishna M, Ryland GL, Campbell IG, Gorringe KL.

    BMC Cancer. 2011 May 17;11:173.

    PMID:
    21575258
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival.

    Batra J, Nagle CM, O'Mara T, Higgins M, Dong Y, Tan OL, Lose F, Skeie LM, Srinivasan S, Bolton KL, Song H, Ramus SJ, Gayther SA, Pharoah PD, Kedda MA, Spurdle AB, Clements JA.

    BMC Cancer. 2011 Apr 1;11:119.

    PMID:
    21457553
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Interaction and uptake of exosomes by ovarian cancer cells.

    Escrevente C, Keller S, Altevogt P, Costa J.

    BMC Cancer. 2011 Mar 27;11:108.

    PMID:
    21439085
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    CXCL12 expression by healthy and malignant ovarian epithelial cells.

    Machelon V, Gaudin F, Camilleri-Broët S, Nasreddine S, Bouchet-Delbos L, Pujade-Lauraine E, Alexandre J, Gladieff L, Arenzana-Seisdedos F, Emilie D, Prévot S, Broët P, Balabanian K.

    BMC Cancer. 2011 Mar 16;11:97.

    PMID:
    21410972
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III--the OVAR-IMRT-02 Study.

    Rochet N, Kieser M, Sterzing F, Krause S, Lindel K, Harms W, Eichbaum MH, Schneeweiss A, Sohn C, Debus J.

    BMC Cancer. 2011 Jan 28;11:41.

    PMID:
    21276234
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk